Following Norwegian patients with spontaneous coronary artery dissection to understand risks and complications
Follows adults hospitalized with spontaneous coronary artery dissection to study risk factors and complications.
Plain-language title generated from the registry record
Registry title: Norwegian Spontaneous Coronary Artery Dissection Study
Key facts
- Where
- Bergen and Oslo, NorwaySee the 3 sites
Where in Norway
- Haukeland University HospitalBergen, NorwayTaking people
- Akershus University HospitalOslo, NorwayTaking people
- Rikshospitalet, Oslo University HospitalOslo, NorwayTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Oslo University Hospital
- Trial code
- NCT07317323
- Record updated
- 5 January 2026
- Original description
The Norwegian Spontaneous Coronary Artery Dissection Study (NOR-SCAD) is a national, multicenter prospective observational study conducted at major hospitals in Norway. The study investigates risk factors and complications of spontaneous coronary artery dissection (SCAD). Patients aged 18 years or older who are hospitalized with SCAD are recruited during the index hospitalization. Each participant will be followed for 52 weeks with scheduled visits at 8 and 12 weeks and a final phone call at 52 weeks. Evaluations include coronary CT angiography (CTA), cardiac assessments, genetic analyses, blood sampling, structured questionnaires, and a cardiopulmonary exercise test (CPET).Read full original descriptionShow less
Norwegian Spontaneous Coronary Artery Dissection Study (NOR-SCAD Study)
The Norwegian Spontaneous Coronary Artery Dissection Study (NOR-SCAD) is a national, multicenter prospective observational study conducted at major hospitals in Norway. The study investigates risk factors and complications of spontaneous coronary artery dissection (SCAD). Patients aged 18 years or older who are hospitalized with SCAD are recruited during the index hospitalization. Each participant will be followed for 52 weeks with scheduled visits at 8 and 12 weeks and a final phone call at 52 weeks. Evaluations include coronary CT angiography (CTA), cardiac assessments, genetic analyses, blood sampling, structured questionnaires, and a cardiopulmonary exercise test (CPET).
Inclusion: Spontaneous coronary artery dissection.
Exclusion: Severe kidney failure; Severe allergic reaction to contrast.